UniProt ID | TLK2_HUMAN | |
---|---|---|
UniProt AC | Q86UE8 | |
Protein Name | Serine/threonine-protein kinase tousled-like 2 | |
Gene Name | TLK2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 772 | |
Subcellular Localization | Nucleus. Cytoplasm, perinuclear region. Cytoplasm, cytoskeleton. Colocalizes with the cytoplasmic intermediate filament system during the G1 phase of the cell cycle. Present in the perinuclear region at S phase and in the nucleus at late G2. | |
Protein Description | Serine/threonine-protein kinase involved in the process of chromatin assembly and probably also DNA replication, transcription, repair, and chromosome segregation. Phosphorylates the chromatin assembly factors ASF1A AND ASF1B. Phosphorylation of ASF1A prevents its proteasome-mediated degradation, thereby enhancing chromatin assembly. Negative regulator of amino acid starvation-induced autophagy.. | |
Protein Sequence | MMEELHSLDPRRQELLEARFTGVGVSKGPLNSESSNQSLCSVGSLSDKEVETPEKKQNDQRNRKRKAEPYETSQGKGTPRGHKISDYFEFAGGSAPGTSPGRSVPPVARSSPQHSLSNPLPRRVEQPLYGLDGSAAKEATEEQSALPTLMSVMLAKPRLDTEQLAQRGAGLCFTFVSAQQNSPSSTGSGNTEHSCSSQKQISIQHRQTQSDLTIEKISALENSKNSDLEKKEGRIDDLLRANCDLRRQIDEQQKMLEKYKERLNRCVTMSKKLLIEKSKQEKMACRDKSMQDRLRLGHFTTVRHGASFTEQWTDGYAFQNLIKQQERINSQREEIERQRKMLAKRKPPAMGQAPPATNEQKQRKSKTNGAENETPSSGNTELKDTAPALGAHSLLRLTLAEYHEQEEIFKLRLGHLKKEEAEIQAELERLERVRNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVTPEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRKSVSTSSPAGAAIASTSGASNNSSSN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Phosphorylation | -MMEELHSLDPRRQE -CHHHHHHCCHHHHH | 47.28 | 27732954 | |
26 | Phosphorylation | RFTGVGVSKGPLNSE HHCCCCCCCCCCCCC | 26.43 | 30576142 | |
26 (in isoform 2) | Phosphorylation | - | 26.43 | 27251275 | |
32 | Phosphorylation | VSKGPLNSESSNQSL CCCCCCCCCCCCCCC | 46.68 | 25159151 | |
34 | Phosphorylation | KGPLNSESSNQSLCS CCCCCCCCCCCCCCC | 34.12 | 25159151 | |
35 | Phosphorylation | GPLNSESSNQSLCSV CCCCCCCCCCCCCCC | 34.53 | 25159151 | |
35 (in isoform 2) | Phosphorylation | - | 34.53 | 27251275 | |
38 | Phosphorylation | NSESSNQSLCSVGSL CCCCCCCCCCCCCCC | 35.28 | 25159151 | |
38 (in isoform 2) | Phosphorylation | - | 35.28 | 27251275 | |
41 | Phosphorylation | SSNQSLCSVGSLSDK CCCCCCCCCCCCCHH | 34.50 | 25159151 | |
44 | Phosphorylation | QSLCSVGSLSDKEVE CCCCCCCCCCHHCCC | 23.65 | 25159151 | |
44 (in isoform 2) | Phosphorylation | - | 23.65 | 27251275 | |
46 | Phosphorylation | LCSVGSLSDKEVETP CCCCCCCCHHCCCCC | 48.62 | 25159151 | |
46 (in isoform 2) | Phosphorylation | - | 48.62 | 27251275 | |
52 | Phosphorylation | LSDKEVETPEKKQND CCHHCCCCCHHHHHH | 41.76 | 25022875 | |
70 | Phosphorylation | RKRKAEPYETSQGKG HHHCCCCCCCCCCCC | 24.28 | 20873877 | |
72 | Phosphorylation | RKAEPYETSQGKGTP HCCCCCCCCCCCCCC | 22.10 | 26055452 | |
73 | Phosphorylation | KAEPYETSQGKGTPR CCCCCCCCCCCCCCC | 25.62 | 25159151 | |
73 (in isoform 2) | Phosphorylation | - | 25.62 | 24719451 | |
78 | Phosphorylation | ETSQGKGTPRGHKIS CCCCCCCCCCCCCCC | 17.19 | 25159151 | |
78 (in isoform 2) | Phosphorylation | - | 17.19 | 24719451 | |
78 (in isoform 3) | Phosphorylation | - | 17.19 | 25159151 | |
85 | Phosphorylation | TPRGHKISDYFEFAG CCCCCCCCCCEEECC | 30.94 | 28796482 | |
87 | Phosphorylation | RGHKISDYFEFAGGS CCCCCCCCEEECCCC | 9.75 | 28796482 | |
94 | Phosphorylation | YFEFAGGSAPGTSPG CEEECCCCCCCCCCC | 30.30 | 22167270 | |
94 (in isoform 2) | Phosphorylation | - | 30.30 | 24719451 | |
98 | Phosphorylation | AGGSAPGTSPGRSVP CCCCCCCCCCCCCCC | 30.59 | 29255136 | |
98 (in isoform 2) | Phosphorylation | - | 30.59 | 24719451 | |
99 | Phosphorylation | GGSAPGTSPGRSVPP CCCCCCCCCCCCCCC | 31.13 | 29255136 | |
99 (in isoform 2) | Phosphorylation | - | 31.13 | 27251275 | |
102 (in isoform 3) | Phosphorylation | - | 37.55 | 25159151 | |
103 | Phosphorylation | PGTSPGRSVPPVARS CCCCCCCCCCCCCCC | 44.91 | - | |
110 | Phosphorylation | SVPPVARSSPQHSLS CCCCCCCCCCCCCCC | 36.31 | 23927012 | |
110 (in isoform 2) | Phosphorylation | - | 36.31 | - | |
111 | Phosphorylation | VPPVARSSPQHSLSN CCCCCCCCCCCCCCC | 24.03 | 23401153 | |
111 (in isoform 2) | Phosphorylation | - | 24.03 | 24719451 | |
115 | Phosphorylation | ARSSPQHSLSNPLPR CCCCCCCCCCCCCCC | 28.39 | 25159151 | |
115 (in isoform 2) | Phosphorylation | - | 28.39 | 24719451 | |
117 | Phosphorylation | SSPQHSLSNPLPRRV CCCCCCCCCCCCCCC | 39.14 | 23401153 | |
117 (in isoform 2) | Phosphorylation | - | 39.14 | 24719451 | |
124 (in isoform 3) | Ubiquitination | - | 9.40 | 21906983 | |
129 | Phosphorylation | RRVEQPLYGLDGSAA CCCCCCCCCCCCHHH | 23.48 | 23403867 | |
134 | Phosphorylation | PLYGLDGSAAKEATE CCCCCCCHHHHHHHH | 25.39 | 30266825 | |
134 (in isoform 2) | Phosphorylation | - | 25.39 | 27251275 | |
140 | Phosphorylation | GSAAKEATEEQSALP CHHHHHHHHHHHHHH | 40.94 | 25849741 | |
140 (in isoform 2) | Phosphorylation | - | 40.94 | 27251275 | |
144 | Phosphorylation | KEATEEQSALPTLMS HHHHHHHHHHHHHHH | 34.74 | 29514088 | |
144 (in isoform 2) | Phosphorylation | - | 34.74 | 27251275 | |
148 | O-linked_Glycosylation | EEQSALPTLMSVMLA HHHHHHHHHHHHHHH | 35.62 | 31492838 | |
148 | Phosphorylation | EEQSALPTLMSVMLA HHHHHHHHHHHHHHH | 35.62 | 29514088 | |
156 | Ubiquitination | LMSVMLAKPRLDTEQ HHHHHHHCCCCCHHH | 27.06 | 2190698 | |
156 (in isoform 1) | Ubiquitination | - | 27.06 | 21906983 | |
156 (in isoform 2) | Ubiquitination | - | 27.06 | 21906983 | |
174 | Phosphorylation | RGAGLCFTFVSAQQN CCCCCEEEEEEECCC | 23.33 | 27080861 | |
177 | Phosphorylation | GLCFTFVSAQQNSPS CCEEEEEEECCCCCC | 19.03 | 30576142 | |
177 (in isoform 2) | Phosphorylation | - | 19.03 | 24719451 | |
182 | Phosphorylation | FVSAQQNSPSSTGSG EEEECCCCCCCCCCC | 23.09 | 21712546 | |
182 (in isoform 2) | Phosphorylation | - | 23.09 | 27251275 | |
184 | Phosphorylation | SAQQNSPSSTGSGNT EECCCCCCCCCCCCC | 40.11 | 27080861 | |
185 | Phosphorylation | AQQNSPSSTGSGNTE ECCCCCCCCCCCCCC | 39.92 | 30576142 | |
186 | Phosphorylation | QQNSPSSTGSGNTEH CCCCCCCCCCCCCCC | 39.44 | 27080861 | |
188 | Phosphorylation | NSPSSTGSGNTEHSC CCCCCCCCCCCCCCC | 29.02 | 27080861 | |
191 | Phosphorylation | SSTGSGNTEHSCSSQ CCCCCCCCCCCCCCC | 38.30 | 27080861 | |
194 | Phosphorylation | GSGNTEHSCSSQKQI CCCCCCCCCCCCCEE | 14.95 | 27080861 | |
196 | Phosphorylation | GNTEHSCSSQKQISI CCCCCCCCCCCEEEE | 38.53 | 27251275 | |
197 | Phosphorylation | NTEHSCSSQKQISIQ CCCCCCCCCCEEEEE | 45.80 | 27080861 | |
218 | Phosphorylation | DLTIEKISALENSKN CCHHHHHHHHHHCCC | 37.56 | 29759185 | |
223 | Phosphorylation | KISALENSKNSDLEK HHHHHHHCCCCHHHH | 24.68 | 29759185 | |
224 | Ubiquitination | ISALENSKNSDLEKK HHHHHHCCCCHHHHH | 72.55 | - | |
226 | Phosphorylation | ALENSKNSDLEKKEG HHHHCCCCHHHHHCC | 47.51 | 25278378 | |
259 | Phosphorylation | QQKMLEKYKERLNRC HHHHHHHHHHHHHHH | 14.54 | 22817900 | |
268 | Phosphorylation | ERLNRCVTMSKKLLI HHHHHHHHHHHHHHH | 21.25 | 29759185 | |
270 | Phosphorylation | LNRCVTMSKKLLIEK HHHHHHHHHHHHHHH | 19.78 | 29759185 | |
300 | Phosphorylation | RLRLGHFTTVRHGAS HHHHCCCEECCCCCC | 20.78 | 23917254 | |
301 | Phosphorylation | LRLGHFTTVRHGASF HHHCCCEECCCCCCC | 18.01 | 23186163 | |
307 | Phosphorylation | TTVRHGASFTEQWTD EECCCCCCCCCCCCC | 36.98 | 28450419 | |
309 | Phosphorylation | VRHGASFTEQWTDGY CCCCCCCCCCCCCHH | 25.44 | 28450419 | |
309 (in isoform 2) | Phosphorylation | - | 25.44 | 27251275 | |
313 | Phosphorylation | ASFTEQWTDGYAFQN CCCCCCCCCHHHHHH | 21.17 | 28450419 | |
316 | Phosphorylation | TEQWTDGYAFQNLIK CCCCCCHHHHHHHHH | 13.67 | 28450419 | |
357 | Phosphorylation | MGQAPPATNEQKQRK CCCCCCCCHHHHHHH | 45.09 | 27470641 | |
393 | Phosphorylation | APALGAHSLLRLTLA HHHCCHHHHHHHHHH | 28.68 | 24719451 | |
418 | Ubiquitination | LRLGHLKKEEAEIQA HHHCCCCHHHHHHHH | 68.12 | - | |
450 | Phosphorylation | RIHNEDNSQFKDHPT HHHCCCCCHHCCCCC | 49.68 | 23312004 | |
491 | Ubiquitination | EQRYVAVKIHQLNKN CCHHHEEEHHHHCCC | 25.41 | - | |
497 | Ubiquitination | VKIHQLNKNWRDEKK EEHHHHCCCCCHHHH | 67.49 | - | |
519 | Ubiquitination | CREYRIHKELDHPRI HHHHHHHHHCCCCCE | 58.56 | - | |
565 | Acetylation | QHKLMSEKEARSIIM HHCCCCHHHHHHHHH | 49.74 | 25953088 | |
617 | Phosphorylation | KITDFGLSKIMDDDS EEECCCCCCCCCCCC | 22.10 | 21815630 | |
679 | Acetylation | YQCLYGRKPFGHNQS HHHHHCCCCCCCCHH | 40.09 | 26051181 | |
686 | Phosphorylation | KPFGHNQSQQDILQE CCCCCCHHHHHHHHH | 34.82 | 20873877 | |
695 | Phosphorylation | QDILQENTILKATEV HHHHHHCCCEEEEEC | 27.25 | 20071362 | |
724 | Phosphorylation | FIRRCLAYRKEDRID HHHHHHHHCCCCCCC | 14.85 | 22817900 | |
731 (in isoform 2) | Phosphorylation | - | 32.82 | - | |
739 (in isoform 2) | Phosphorylation | - | 22.89 | 24719451 | |
740 (in isoform 2) | Phosphorylation | - | 13.97 | 27251275 | |
748 | Phosphorylation | LLPHIRKSVSTSSPA HHHHHHHHCCCCCCC | 16.08 | 23403867 | |
748 (in isoform 2) | Phosphorylation | - | 16.08 | 27251275 | |
749 (in isoform 2) | Phosphorylation | - | 8.97 | 27251275 | |
750 | Phosphorylation | PHIRKSVSTSSPAGA HHHHHHCCCCCCCCC | 29.66 | 25159151 | |
751 | Phosphorylation | HIRKSVSTSSPAGAA HHHHHCCCCCCCCCH | 30.94 | 25627689 | |
752 | Phosphorylation | IRKSVSTSSPAGAAI HHHHCCCCCCCCCHH | 27.15 | 25262027 | |
753 | Phosphorylation | RKSVSTSSPAGAAIA HHHCCCCCCCCCHHH | 20.89 | 25159151 | |
761 | Phosphorylation | PAGAAIASTSGASNN CCCCHHHCCCCCCCC | 19.59 | 21712546 | |
762 | Phosphorylation | AGAAIASTSGASNNS CCCHHHCCCCCCCCC | 23.35 | 23403867 | |
763 | Phosphorylation | GAAIASTSGASNNSS CCHHHCCCCCCCCCC | 29.84 | 23403867 | |
766 | Phosphorylation | IASTSGASNNSSSN- HHCCCCCCCCCCCC- | 39.82 | 22115753 | |
769 | Phosphorylation | TSGASNNSSSN---- CCCCCCCCCCC---- | 39.12 | 25159151 | |
770 | Phosphorylation | SGASNNSSSN----- CCCCCCCCCC----- | 35.70 | 25159151 | |
771 | Phosphorylation | GASNNSSSN------ CCCCCCCCC------ | 46.51 | 25159151 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
750 | S | Phosphorylation |
| 12955071 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TLK2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ASF1A_HUMAN | ASF1A | physical | 11470414 | |
ASF1B_HUMAN | ASF1B | physical | 11470414 | |
TLK1_HUMAN | TLK1 | physical | 10523312 | |
ASF1B_HUMAN | ASF1B | physical | 17940067 | |
ASF1A_HUMAN | ASF1A | physical | 20016786 | |
ASF1B_HUMAN | ASF1B | physical | 20016786 | |
XPO7_HUMAN | XPO7 | physical | 22939629 | |
XPO1_HUMAN | XPO1 | physical | 22939629 | |
TLK1_HUMAN | TLK1 | physical | 28514442 | |
RS27A_HUMAN | RPS27A | physical | 28514442 | |
CABIN_HUMAN | CABIN1 | physical | 28514442 | |
AMOL1_HUMAN | AMOTL1 | physical | 27173435 | |
IFFO1_HUMAN | IFFO1 | physical | 27173435 | |
CDAC1_HUMAN | CDADC1 | physical | 27173435 | |
SCML1_HUMAN | SCML1 | physical | 27173435 | |
COBL1_HUMAN | COBLL1 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32; TYR-70; THR-72;SER-73; SER-94; THR-98; SER-99; SER-110; SER-111; SER-115; SER-117;SER-134; SER-196; THR-300; SER-769; SER-770 AND SER-771, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99; SER-111; SER-115 ANDSER-771, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99 AND SER-753, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99, AND MASSSPECTROMETRY. |